<DOC>
	<DOCNO>NCT00523705</DOCNO>
	<brief_summary>The purpose pilot study determine efficacy safety escitalopram administer premenstrually ( day 14 day 2 menstrual cycle ) severe PMS young woman age 15-19 year .</brief_summary>
	<brief_title>Escitalopram Premenstrual Syndrome ( PMS ) Teens : A Pilot Study</brief_title>
	<detailed_description>The medication study serotonin reuptake inhibitor ( SSRI ) , class consider first-line treatment severe PMS time . Although data indicate young woman PMS teen year report symptom symptom severity adult woman , clinical trial include age group , information efficacy safety treatment serotonergic antidepressant PMS teen .</detailed_description>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Females 1519 year age Regular menstrual cycle 2235 day In general good health Medically approve birth control method sexually active Evidence ovulation Meeting symptom criterion PMS Signed informed consent Subjects age 18 must also sign parental consent Current use treatment PMS . Psychotropic medication may compromise study drug . Pregnancy , intend pregnancy breast feeding . Not use medically approve birth control method sexually active . Significant medical gynecological abnormality . Irregular menses , gynecologic disorder . Any severe unstable medical illness . Any current major psychiatric diagnosis history major psychiatric diagnosis . Any current history alcohol abuse , drug abuse , suicide attempt , bipolar disorder , psychosis severe personality disorder . Use triptans ( Imitrex , Zomig , Frova , Maxalt , Axert , Amerge , Relpax ) . Use medicine include dextromethorphan Tylenol Vicks cough medicine . Use pain medication meperidine . Use herbal product St John 's Wort may increase serotonin . Use monoamine oxidase inhibitor ( MAOIs ) , pimozide citalopram hydrobromide . Drugs metabolize CYP2D6 combination CYP3A4 CYP2D6 inhibitor . Hypersensitivity escitalopram citalopram .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>premenstrual syndrome</keyword>
	<keyword>PMS</keyword>
	<keyword>PMDD</keyword>
	<keyword>treatment</keyword>
	<keyword>SSRI</keyword>
</DOC>